ReviewFrontiers in immunology2026
Toward a chemotherapy and allo-HSCT free future: the evolution of treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Qixing YangPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.